The effectiveness of Parent-Child Interaction Therapy versus methylphenidate in preschool children with ADHD and disruptive behavior problems with insufficient improvement through Parent Management Training. - STAP Study of Treatment of ADHD and behavior problems in Preschool

Accare0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•1. 1. Children of both sexes, of any ethnic and cultural background, ages 2;6 to 6 years.
•2. At time of referral A DSM-IV (American Psychiatric Association, 1994) consensus diagnosis of ADHD any subtype including ADHD-Not Otherwise Specified.
•3. At time of referral presence of oppositional behavior as evidenced through either a DSM-IV (American Psychiatric Association, 1994) consensus diagnosis of ODD, or Conduct Disorder, or Disruptive Behavior Disorder Not Otherwise Specified, or a baseline primary caretakers ECBI score >= 131 and identification of minimally three target problem behaviors.
•4. Previous treatment through PMT has resulted in less than 30% reduction on the primary caretaker ECBI score, or on the Externalizing scale of the C-TRF/1*-5 or has resulted in a rating of less than improved on the Clinical Global Impression Scale of improvement by the clinician.
•5. Full Scale IQ equivalent of >70.
•6. The same primary caretaker for at least 6 months before inclusion.
•7. Parents have provided informed consent to participate in the study, in accordance with Dutch ethical regulations.
•8. Systolic and diastolic blood pressure below 95th percentile for age and gender.

•1. 1. Previous PCIT; other forms of previous treatments are acceptable, including the use of previous psychotropic medication.
•2. The child has a major medical condition that would interfere with involvement in a long-term study or could be affected negatively by methylphenidate, including the presence of schizophrenia, hyperthyroidism, cardiac arrhythmias, angina pectoris, and glaucoma.
•3. Ongoing psychosocial treatment or ongoing treatment with psychotropic medication.
•4. Inability of the parent to understand or follow study instructions.
•5. Patients whose families anticipate a move outside the geographic range of the investigative site.
•6. Use of any other psychotropic medication or has taken an investigational drug in the past 30 days.

发起方

Accare